The company intends to use the funds for capital expenditures.
Led by Wayne Woodard, chief executive officer, Argonaut provides contract manufacturing for suppliers of molecular diagnostic and life science reagents and consumables. The company’s team supports all product stages, from launch to revitalization, with services such as project planning, supplier management and global logistics.
Clients receives products compliant with applicable regulations and savings realized through cost variabilization.
Argonaut MS is backed by venture capital firm Telegraph Hill Partners.